![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Shanghai Menon Animal Nutrition Technology
301156
5
Nanjing Railway New Technology
301016
US Stock MarketDetailed Quotes
PBM Psyence Biomedical
- 0.4620
- -0.1190-20.48%
Close Apr 4 16:00 ET
- 0.4840
- +0.0220+4.76%
Post 19:53 ET
2.09MMarket Cap0.00P/E (TTM)
0.5793High0.4400Low168.76KVolume0.5793Open0.5810Pre Close85.27KTurnover6.05%Turnover Ratio0.00P/E (Static)4.53MShares108.000052wk High-0.16P/B1.29MFloat Cap0.440052wk Low--Dividend TTM2.79MShs Float1091.2500Historical High--Div YieldTTM23.98%Amplitude0.4400Historical Low0.5050Avg Price1Lot Size
Psyence Biomedical Stock Forum
Sign in to post a comment
11
8
$Psyence Biomedical (PBM.US)$
Psyence's Game-Changing Phase IIb Trial Takes On Cancer Mental Health Crisis
Psyence's Game-Changing Phase IIb Trial Takes On Cancer Mental Health Crisis
$Psyence Biomedical (PBM.US)$
Corporate Update: Psyence Biomedical Ltd Redefines Psychedelic Medicine with a Multi-Asset Strategy, Advancing Clinical Trials and Scalable Manufacturing
Psyence Biomedical (NASDAQ: PBM) provided a corporate update highlighting its progress in psychedelic medicine development. The company is conducting a Phase IIb clinical trial in Australia, focusing on adjustment disorder in cancer patients, benefiting from up to 43.5% R&D tax rebates and favorable regulatory f...
Corporate Update: Psyence Biomedical Ltd Redefines Psychedelic Medicine with a Multi-Asset Strategy, Advancing Clinical Trials and Scalable Manufacturing
Psyence Biomedical (NASDAQ: PBM) provided a corporate update highlighting its progress in psychedelic medicine development. The company is conducting a Phase IIb clinical trial in Australia, focusing on adjustment disorder in cancer patients, benefiting from up to 43.5% R&D tax rebates and favorable regulatory f...
$Psyence Biomedical (PBM.US)$
Top Columbia Psychiatrist Joins Psyence's Psilocybin Clinical Trial Team
Top Columbia Psychiatrist Joins Psyence's Psilocybin Clinical Trial Team
2
$Psyence Biomedical (PBM.US)$ You're killing me man
3
1
NOTE!
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; F...
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; F...
80
6
$Psyence Biomedical (PBM.US)$
ATL 4 days ago.
Looking for DCB.
8.88% SI
6 LTB....
2 days of hard borrowing to keep it knocked down.
312.95 CTB
ATL 4 days ago.
Looking for DCB.
8.88% SI
6 LTB....
2 days of hard borrowing to keep it knocked down.
312.95 CTB
No comment yet
Market Insights
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
74693490 : Thank you.![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
GYM-DTGPP : thank you Jaguar. is there any target price for Newton Golf?
Mangkawat : $Quantum Computing (QUBT.US)$ and $Kingold Jewelry (KGJI.US)$ did it related to tariffs?
Sean Parker : $SharpLink Gaming (SBET.US)$ just had 3 huge volume alerts. more than 600k
151187341 : Thank you
View more comments...